Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01X OTHER ANTIBACTERIALS
J01XX Other antibacterials
J01XX12 Lefamulin
D11632 Lefamulin acetate (USAN) <US>
USP drug classification [BR:br08302]
Antibacterials
Antibacterials, Other
Lefamulin
D11632 Lefamulin acetate (USAN)
Drug groups [BR:br08330]
Antibacterial
DG01813 Pleuromutilin
DG03066 Lefamulin
D11632 Lefamulin acetate
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG03066 Lefamulin
D11632 Lefamulin acetate
Antimicrobials [BR:br08307]
Antibacterials
Protein biosynthesis inhibitor
Pleuromutilin
D11632 Lefamulin acetate (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11632
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11632
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11632
Drug groups [BR:br08330]
Antibacterial
DG01813 Pleuromutilin
DG03066 Lefamulin
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG03066 Lefamulin
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Protein biosynthesis inhibitor
Pleuromutilin
DG03066 Lefamulin